Abstract

Senescent cells accumulate in different organs and develop a senescence-associated secretory phenotype (SASP), associated with the development of age-related pathologies. The constitution of the SASP varies among cell types and with the method of senescence induction; nevertheless, there is substantial overlap among SASPs, especially the presence of pro-inflammatory cytokines such as IL-1β, IL-1α, IL-6 and IL-8. These cytokines are highly conserved among SASPs and are implicated in the development of several cancers. Here, we report that ROCK inhibition by Y-27632 reduces levels of IL-1α, IL-1β, IL-6 and IL-8 secreted by senescent normal and dysplastic oral keratinocytes without affecting the permanent cell growth arrest. The data indicate some inflammatory genes downregulated by Y-27632 remain downregulated even after repeated passage in the absence of Y-27632. We propose ROCK kinase inhibition as a novel alternative to current strategies to modulate the inflammatory components of the SASP, without compromising the permanent cell growth arrest. This observation potentially has wide clinical applications, given the involvement of senescence in cancer and a wide range of age-related disease. It also suggests care should be exercised when using Y-27632 to facilitate cell expansion of primary cells, as its effects on gene expression are not entirely reversible.

Highlights

  • Senescent cells accumulate in different organs and develop a senescence-associated secretory phenotype (SASP), associated with the development of age-related pathologies

  • Due to its ability to inhibit IL-1 signalling and the importance of the IL-1 pathway for the development of the SASP, we investigated the effects of Y-27632 on presenescent and senescent cells and examined whether Y-27632 could modulate the expression of commonly expressed SASP factors related to cancer development

  • Senescent cells accumulate in different organs and develop a secretory phenotype, known as the SASP, which has been related to the development of age-related pathologies [34]

Read more

Summary

Introduction

Senescent cells accumulate in different organs and develop a senescence-associated secretory phenotype (SASP), associated with the development of age-related pathologies. We propose ROCK kinase inhibition as a novel alternative to current strategies to modulate the inflammatory components of the SASP, without compromising the permanent cell growth arrest This observation potentially has wide clinical applications, given the involvement of senescence in cancer and a wide range of age-related disease. Abbreviations IL, interleukin; IL-1R1, interleukin 1 receptor 1; NF-jB, nuclear factor kappa-light-chain-enhancer of activated B cells; NOK, normal oral keratinocyte; OD, oral dysplasia; p38 MPAK, p38 mitogen-activated protein kinase; ROCK, Rho kinase; SA-b-Gal, senescence-associated beta-galactosidase; SASP, senescence-associated secretory phenotype.

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.